BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9510042)

  • 1. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
    Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
    Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications.
    Nylander K; Anneroth G; Gustafsson H; Roos G; Stenling R; Zackrisson B
    Acta Oncol; 1994; 33(1):23-8. PubMed ID: 8142119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
    Bennett MH; Wilson GD; Dische S; Saunders MI; Martindale CA; Robinson BM; O'Halloran AE; Leslie MD; Laing JH
    Br J Cancer; 1992 Jun; 65(6):870-8. PubMed ID: 1616858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
    Wilson GD; Dische S; Saunders MI
    Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.
    Cooke LD; Cooke TG; Forster G; Jones AS; Stell PM
    Br J Cancer; 1994 Apr; 69(4):717-20. PubMed ID: 8142259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
    Haustermans K; Fowler JF
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
    Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
    Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer.
    Corvò R; Paoli G; Giaretti W; Sanguineti G; Geido E; Benasso M; Margarino G; Vitale V
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):57-63. PubMed ID: 10758305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
    Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
    Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
    Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
    Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
    Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
    Palmqvist R; Oberg A; Bergström C; Rutegård JN; Zackrisson B; Stenling R
    Br J Cancer; 1998 Mar; 77(6):917-25. PubMed ID: 9528835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
    Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy.
    Zackrisson B; Gustafsson H; Stenling R; Flygare P; Wilson GD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):677-83. PubMed ID: 9240632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
    Stausbøl-Grøn B; Overgaard J
    Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.